Diagnostic yield of long-read sequencing for rare diseases: a systematic review
Frontiers in Genetics · 05.06.2026 · 17
DOI: 10.3389/fgene.2026.1809097 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Genetics, online erschienen am 05.06.2026. Verfasst von Amal Abdulsalam Ibrahim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Nearly half of patients with rare genetic disorders remain undiagnosed, which may in part be due to limitations of current short-read sequencing (SRS) approaches in detecting complex genomic alterations. Long-read whole genome sequencing (lrWGS) technologies can address these limitations through enhanced detection of structural variants (SVs), repetitive regions, and epigenetic changes.
Methods
To evaluate the diagnostic yield of lrWGS in patients with rare genetic diseases receiving inconclusive or negative results from standard testing, we searched the PubMed, Science Direct, Scopus, and ProQuest databases to July 2025 for studies applying lrWGS to unresolved rare disease cases and reporting diagnostic outcomes. Risk of bias was assessed using the QUADAS-2 tool.
Results
Nine studies involving 646 previously unresolved cases that underwent lrWGS met the inclusion criteria. Of these, 29 individuals (24 unique diagnoses involving 25 genes) received a definitive diagnosis through lrWGS, a diagnostic yield of 4.5%. SVs accounted for the majority of identified variants (41.67%), followed by combined SV/single-nucleotide variants (20.83%), methylation changes (16.67%), and other variant types (copy number variations, indels, and tandem repeats). Most detected variants were in regions typically inaccessible to short-read whole-exome sequencing (WES). lrWGS also enabled phasing and methylation analysis in a single assay, which was valuable for compound-heterozygosity detection and diagnostic interpretation. Conclusion lrWGS shows clear potential for improving diagnostic rates in previously unresolved rare disease cases, particularly when applied after WES and combined with advanced tools such as phasing and methylation profiling. As technologies evolve and become more accessible, lrWGS may increasingly become a first-tier diagnostic approach, especially in phenotypically complex conditions. Systematic Review Registration https://osf.io/y5azb/overview , identifier 10.17605/OSF.IO/Y5AZB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
- College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.
- Laboratory of Genomic Medicine, Sidra Medicine, Doha, Qatar.
- Department of Genetic Medicine, Weill Cornell Medicine, Doha, Qatar.
Zitieren
APA
Ibrahim, A. A., Fakhro, K. A., & Abdallah, A. M. (2026). Diagnostic yield of long-read sequencing for rare diseases: a systematic review. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1809097
Vancouver
Ibrahim AA, Fakhro KA, Abdallah AM. Diagnostic yield of long-read sequencing for rare diseases: a systematic review. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1809097
BibTeX
@article{Ibrahim2026,
author = {Ibrahim, Amal Abdulsalam and Fakhro, Khalid A and Abdallah, Atiyeh M},
title = {Diagnostic yield of long-read sequencing for rare diseases: a systematic review},
journal = {Frontiers in Genetics},
year = {2026},
volume = {17},
doi = {10.3389/fgene.2026.1809097}
}
EUVIMED